Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Comparative Effectiveness Review Number 73 by Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Comparative Effectiveness Review Number 73

Agency for Healthcare Resea And Quality, U.S. Department of Health and Human Services

104 pages • missing pub info (view editions)

nonfiction health informative medium-paced
Powered by AI (Beta)
Loading...

Description

Plasma-cell dyscrasias (PCDs) are a group of neoplastic disorders characterized by the uninhibited expansion of a monoclonal population of malignant plasma cells. Multiple myeloma (MM) is the most common malignant plasma-cell tumor, accounting for...

Read more

Community Reviews

Loading...

Content Warnings

Loading...